U.S. Professional Services Stock News

NYSE:KVUE
NYSE:KVUEPersonal Products

Kenvue (KVUE): Profit Margin Jump Challenges Concerns Over Quality of Earnings and Growth Outlook

Kenvue (KVUE) reported revenue expected to grow 3.1% per year, trailing the broader US market’s 10.5% annual pace. The company’s earnings are projected to rise 11.5% per year, also below the market’s 16% average. Notably, earnings jumped 34.6% over the past year, far outpacing its own 5-year growth trend of 5.5% per year. Net profit margins expanded to 9.5% from last year’s 6.9%, even as a one-off loss of $683 million weighed on results. See our full analysis for Kenvue. Next, we’ll see how...
NasdaqGM:AXSM
NasdaqGM:AXSMPharmaceuticals

Axsome Therapeutics (AXSM): Losses Worsen 24.5% Annually, Testing Bullish Growth Narratives

Axsome Therapeutics (AXSM) remains unprofitable, recording annualized losses that have deepened by 24.5% per year over the past five years. Margins remain negative and there has been no recent sign of net margin improvement. Despite the continued losses, shares now trade at $134.99, well below the company’s estimated fair value of $758.62. Analyst forecasts point to annual earnings growth of 67.15% and a return to profitability within three years. Investors are watching closely to see whether...
NasdaqGS:FSTR
NasdaqGS:FSTRMachinery

L.B. Foster (FSTR) Net Margin Drops to 1%, Raising Questions on Turnaround Narrative

L.B. Foster (FSTR) reported a net profit margin of 1%, marking a notable decline from last year's 8%. Negative earnings growth offset a track record of returning to profitability over five years with average annual earnings growth of 0.8%. The market will compare this backdrop to ambitious forecasts, with revenue expected to grow 6.9% per year, which is slower than the US market average of 10.5%. Earnings are projected to accelerate at 93.4% per year over the next three years. Despite shares...
NasdaqGS:CIFR
NasdaqGS:CIFRSoftware

Cipher Mining (CIFR): Losses Worsen, Challenging Bullish Growth Narratives Despite Strong Profitability Forecasts

Cipher Mining (CIFR) remains unprofitable, with losses having accelerated at an average rate of 10.3% per year over the past five years. Despite the current challenges, including a Price-to-Sales Ratio of 43.4x, which sits well above both its peer group’s 28.7x average and the broader US software industry’s 5.3x benchmark, investors are closely watching the company’s forecast for 34.8% annual revenue growth and a robust 67.96% earnings growth per year. This positions Cipher on a pathway to...
NasdaqGS:ERIE
NasdaqGS:ERIEInsurance

Is Now the Right Time to Reassess Erie Indemnity After a 30% Drop in 2025?

Wondering if Erie Indemnity is still a worthy pick or whether the recent headlines signal a new opportunity? You are definitely not alone, especially if the stock's recent moves have caught your attention. The share price has taken a sharp turn lately, dropping 13.5% over the past week and now down 30.3% year-to-date. This brings one-year returns to -28%, despite a solid gain over the past five years. Recent news has cast the entire insurance sector into the spotlight, with investors...
NasdaqGM:III
NasdaqGM:IIIIT

Information Services Group (III): Profit Rise Driven by $5.3M One-Off Challenges Quality Narrative

Information Services Group (III) is forecast to grow earnings at 13.26% per year, lagging the projected 16.1% annual growth for the US market. Revenue is expected to rise by 5.1% per year compared to the broader market’s 10.5% forecast. Profitability has just turned positive, but a one-off gain of $5.3 million has made recent margin trends less straightforward. Over the past five years, the company’s earnings have declined by 12.8% per year, painting a complex picture for investors looking...
NYSE:PEG
NYSE:PEGIntegrated Utilities

PEG Net Margin Expansion Reinforces Bullish Narratives Despite Premium Valuation Concerns

Public Service Enterprise Group (PEG) posted a net profit margin of 17.8%, up from last year’s 16.1%. EPS growth came in at 19.9% over the past year, outpacing the company’s 5-year average of 14.5% per year and signaling a notable acceleration in profitability. Forward-looking forecasts call for revenue growth of 4.8% per year and earnings growth of 6.2% per year, which are both slower than the broader US market. Investors weighing these results will be watching PEG’s sustained profit growth...
NYSE:KOS
NYSE:KOSOil and Gas

Kosmos Energy (KOS): Forecasted Annual Profit Growth of 64.9% Sets Up Turnaround Narrative

Kosmos Energy (KOS) has narrowed its losses by an average of 47.8% per year over the last five years. Although sales are forecast to grow at a slower-than-market pace of 3.4% annually, earnings are projected to increase sharply by 64.89% per year. With a share price of $1.48, significantly below its estimated fair value of $10.87, and no notable risk factors currently highlighted, investors will be watching closely as the company aims to reach profitability within three years. These trends...
NYSE:RHLD
NYSE:RHLDProfessional Services

Resolute Holdings Management (RHLD): Net Margin Slips Challenges Quality-Earnings Bull Case

Resolute Holdings Management (RHLD) posted a net profit margin of 24.6%, slipping from 25.9% a year earlier, with negative earnings growth over the past year. Despite the setback, the company stands out for its high quality earnings and trades at a Price-To-Earnings Ratio of 11.6x, which is well below both peer and industry averages. With shares priced at $144.97 against an estimated fair value of $507.15, RHLD now looks compelling on valuation, though minor risks remain around share price...
NasdaqCM:LQDA
NasdaqCM:LQDAPharmaceuticals

Liquidia (LQDA) Losses Worsen Despite Strong 43.7% Revenue Growth Forecast—Profitability Narrative in Focus

Liquidia (LQDA) is forecasting revenue growth of 43.7% per year, far outpacing the US market’s projected 10.5% annual growth rate. Earnings are expected to climb at 62.69% per year and the company is on track to become profitable within the next three years. For now, losses have grown at an annual rate of 25.7% over the past five years without improvement in margins. Investors appear caught between optimism around long-term growth and caution over current unprofitability, especially given...
NYSE:SM
NYSE:SMOil and Gas

SM Energy (SM) Net Margin Declines to 27.1%, Testing Bullish Case on Profit Resilience

SM Energy (SM) reported a net profit margin of 27.1%, falling short of last year’s 34.3%. While the company became profitable over the past five years and averaged 47% annual earnings growth during that period, earnings growth in the most recent year slowed to just 0.2%. Looking ahead, investors are weighing the company’s historically strong profit growth against forecasts that call for a 14.6% annual decline in earnings over the next three years. See our full analysis for SM Energy. Now,...
NYSE:PNW
NYSE:PNWElectric Utilities

Pinnacle West Capital (PNW): Margin Decrease Reinforces Dividend and Financial Stability Concerns

Pinnacle West Capital (PNW) is forecast to grow revenue at 4.7% per year, which trails behind the US market's expected 10.5% annual growth. Earnings are set to rise at a rate of 10.4% per year, while net profit margins have slipped to 11% from 12.7%. Over the past five years, earnings have averaged a 0.9% per year decline. Trading at $89.45 with a Price-To-Earnings Ratio of 18.5x, the stock sits just below its estimated fair value. Strong earnings quality and expectations of profit growth are...
NasdaqGS:KRYS
NasdaqGS:KRYSBiotechs

Krystal Biotech (KRYS): Margin Drop Challenges Bullish Growth Narratives Despite Strong Top-Line Outlook

Krystal Biotech (KRYS) delivered earnings growth of 38.5% over the past year, falling short of its five-year average growth rate of 43.4% per year. The company’s net profit margin came in at 40.8%, a notable drop from 63.7% the previous year. Earnings are projected to expand at 34.4% annually going forward. Solid revenue growth projections and favorable valuation measures provide a strong backdrop. However, the decline in profit margins offers investors a reason to keep a close watch on...
NYSE:GNE
NYSE:GNEElectric Utilities

Genie Energy (GNE): Profit Growth Surges, Challenges Concerns over High Valuation and Margin Stability

Genie Energy (GNE) just posted headline-grabbing growth, with earnings expected to surge 37% per year, which is more than double the US market average of 16.1%. Profit growth over the past year accelerated sharply, jumping 118.9% after several years of declines. Net profit margins also improved from 0.8% to 1.5%. Even with shares trading at $14.8 below an estimated fair value of $58.2, the price-to-earnings ratio sits high at 53.5x against the industry average. This puts future profitability...
NasdaqGS:WGS
NasdaqGS:WGSHealthcare

3 Stocks Including FinWise Bancorp Estimated To Be Priced Below Intrinsic Value

As the United States stock market experiences a period of gains with major indices like the Nasdaq, S&P 500, and Dow Jones Industrial Average posting solid weekly and monthly increases, investors are keenly observing opportunities that may be priced below their intrinsic value. In such an environment, identifying stocks that appear undervalued can be crucial for those looking to capitalize on potential market inefficiencies and enhance portfolio performance.
NasdaqCM:CRGO
NasdaqCM:CRGOLogistics

3 Promising Penny Stocks With Market Caps Under $200M

The United States stock market has recently closed on a high note, with major indices like the Nasdaq, S&P 500, and Dow Jones Industrial Average posting solid weekly and monthly gains. For investors willing to explore beyond the well-known giants, penny stocks—often representing smaller or newer companies—continue to offer intriguing opportunities. Despite being an older term, these stocks can present significant growth potential when backed by strong financials and sound fundamentals.
NasdaqCM:PKBK
NasdaqCM:PKBKBanks

3 Undiscovered Gems In The US Market With Strong Potential

As the U.S. stock market continues to experience robust growth, with major indices like the Nasdaq and S&P 500 posting impressive weekly and monthly gains, investors are increasingly on the lookout for opportunities beyond the well-trodden paths of large-cap giants. In this dynamic landscape, identifying promising small-cap stocks that demonstrate resilience and growth potential can be a rewarding strategy for those seeking to diversify their portfolios amidst broader market optimism.
NasdaqCM:VTGN
NasdaqCM:VTGNBiotechs

Assessing Vistagen Therapeutics’s (VTGN) Valuation After Board Addition of Pharma Executive Paul Edick

Vistagen Therapeutics (VTGN) just named Paul Edick to its Board of Directors, bringing an executive with decades of pharmaceutical leadership to the team. Edick will join the Audit and Compensation Committees. See our latest analysis for Vistagen Therapeutics. Momentum has picked up for Vistagen Therapeutics lately, with the share price climbing nearly 35% over the past three months and putting its year-to-date share price return just under 19%. While the stock’s one-year total shareholder...